Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632420 · ClinicalTrials.gov registry record
Evaluation of Headache and Childbirth in a Chronic Pain Population
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 1,112
- Enrollment target
NCT04632420: Completed study, sponsored by Stanford University.
NCT04632420 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 1,112 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04632420 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 1,112 participants
- Enrollment target
Study Summary
Headache and backache are common symptoms following childbirth. The incidence of these symptoms have been shown to increase during the postpartum period between 5 to 12 months following delivery. By 12 months postpartum up to 45% and 65% of women experience headache and backache, respectively. While studies have reported headache and backache as frequently persistent symptoms beyond the first year postpartum, few studies have specifically interrogated women seeking specialist pain physician input or identified predisposing risk factors. Finally there is little known about typically described pain characteristics of women who suffer with chronic postpartum headache and backache. We aim to compare the prevalence of chronic headache in women that have versus have not experienced childbirth.
Primary Outcome
Percentage of patients with chronic headache in women who have given birth and who have not given birth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,112 participants |
| Start Date | 2019-09-13 |
| Est. Completion | 2020-02-26 |
What the finished NCT04632420 record still lists
NCT04632420 is an observational study that tracks outcomes without assigning an intervention. Its 1,112 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04632420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04632420 about?
NCT04632420 is a clinical study titled "Evaluation of Headache and Childbirth in a Chronic Pain Population". Headache and backache are common symptoms following childbirth. The incidence of these symptoms have been shown to increase during the postpartum period between 5 to 12 months following delivery. By 12 months postpartum up to 45% and 65% of women experience headache and backache, respectively. While...
What is the current status of trial NCT04632420?
This trial is currently completed. The enrollment target is 1,112 participants. The study started on 2019-09-13. Estimated completion is 2020-02-26.
Who is sponsoring clinical trial NCT04632420?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
- NCT06618534 · 1,120 participants · Phase 2
Azithromycin for Meningococcal Carriage
- NCT07164131 · 1,120 participants · Phase 4
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI